These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8842108)

  • 21. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America.
    Phillips EJ; Keystone JS; Kain KC
    Clin Infect Dis; 1996 Nov; 23(5):1171-3. PubMed ID: 8922821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria?
    Warhurst DC
    Ann Trop Med Parasitol; 1984 Apr; 78(2):165. PubMed ID: 6378110
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
    Baird JK; Basri H; Subianto B; Fryauff DJ; McElroy PD; Leksana B; Richie TL; Masbar S; Wignall FS; Hoffman SL
    J Infect Dis; 1995 Jun; 171(6):1678-82. PubMed ID: 7769318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chloroquine sensitivity of Plasmodium vivax in Thailand.
    Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
    Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research progress on Plasmodium vivax chloroquine resistance].
    Li JY; Li Q; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):326-31. PubMed ID: 25345166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primaquine treatment and relapse in Plasmodium vivax malaria.
    Rishikesh K; Saravu K
    Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primaquine treatment for Plasmodium vivax--an essential tool for malaria control and elimination in Papua New Guinea.
    Betuela I; Robinson LJ; Hetzel MW; Laman M; Siba PM; Bassat Q; Mueller I
    P N G Med J; 2014; 57(1-4):68-74. PubMed ID: 26930890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of primaquine in malaria control and elimination in French-speaking Africa].
    Briolant S; Pradines B; Basco LK
    Bull Soc Pathol Exot; 2017 Aug; 110(3):198-206. PubMed ID: 28417346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
    Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
    PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasmodium vivax resistance to primaquine].
    Cabezos J; Durán E; Tomás D; Bada JL
    Med Clin (Barc); 1994 Jun; 103(4):159. PubMed ID: 8072336
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug resistant Plasmodium vivax malaria.
    Whitby M
    J Antimicrob Chemother; 1997 Dec; 40(6):749-52. PubMed ID: 9462425
    [No Abstract]   [Full Text] [Related]  

  • 34. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-malarial drug effects on parasite dynamics in vivax malaria.
    White NJ
    Malar J; 2021 Mar; 20(1):161. PubMed ID: 33743731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
    Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
    Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An insight on drug resistance in Plasmodium vivax, a still neglected human malaria parasite.
    L'Episcopia M; Perrotti E; Severini F; Picot S; Severini C
    Ann Ist Super Sanita; 2020; 56(4):409-418. PubMed ID: 33346166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and immunological analyses of confirmed Plasmodium vivax relapse episodes.
    Maneerattanasak S; Gosi P; Krudsood S; Chimma P; Tongshoob J; Mahakunkijcharoen Y; Sukasem C; Imwong M; Snounou G; Khusmith S
    Malar J; 2017 May; 16(1):228. PubMed ID: 28558712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.